Hepatic resection for ovarian cancer in Germany: a nationwide epidemiological study based on DRG (diagnosis-related groups) data (2020–2024)
Hepatic resection for ovarian cancer is performed regularly in Germany, primarily at high-volume centers, suggesting a growing clinical acceptance of aggressive cytoreduction strategies despite the absence of formal recommendations. Our findings underline the need for prospective, multicenter studies and guideline updates addressing hepatic metastases in ovarian cancer.
Authors
- Björn Lampe
- Miklos Acs (ORCID: https://orcid.org/0000-0003-4706-5541)
- Stefanie Hofmarksrichter
- Niklas Bogovic
- Sandra Gebhard
- Benedikt J. Wagner (ORCID: https://orcid.org/0000-0002-1935-4058)
- Hans J. Schlitt (ORCID: https://orcid.org/0000-0002-3874-0296)
- Veronika Müller (ORCID: https://orcid.org/0000-0002-1398-3187)
- Markus Götz
Institutions
- University Hospital Regensburg (DE)
- Städtische Kliniken Mönchengladbach (DE)
- University of Regensburg (DE)
Publication Details
- Journal
- World Journal of Surgical Oncology
- Published
- 2025-10-20
- DOI
- https://doi.org/10.1186/s12957-025-04064-x
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00